Kevin P. Starr, 10% Owner at Global Blood Therapeutics, Inc. (GBT), sold 108,955 shares at $16.00 ($1.7M) on 2016-12-16, disclosed to the SEC on 2016-12-20.
Open-market sale of $1.7M GBT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FULC | BUY | 2019-07-22 | $1.3M | — | Filing → |
| SAGE | SELL | 2018-04-19 | $10.0M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |